JP5875773B2 - 紫外光測定方法 - Google Patents
紫外光測定方法 Download PDFInfo
- Publication number
- JP5875773B2 JP5875773B2 JP2011063144A JP2011063144A JP5875773B2 JP 5875773 B2 JP5875773 B2 JP 5875773B2 JP 2011063144 A JP2011063144 A JP 2011063144A JP 2011063144 A JP2011063144 A JP 2011063144A JP 5875773 B2 JP5875773 B2 JP 5875773B2
- Authority
- JP
- Japan
- Prior art keywords
- ultraviolet light
- calcium
- cell
- protein
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000691 measurement method Methods 0.000 title claims description 9
- 210000004027 cell Anatomy 0.000 claims description 184
- 108090000623 proteins and genes Proteins 0.000 claims description 107
- 239000011575 calcium Substances 0.000 claims description 99
- 229910052791 calcium Inorganic materials 0.000 claims description 99
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 98
- 102000004169 proteins and genes Human genes 0.000 claims description 85
- 238000000034 method Methods 0.000 claims description 62
- 108090000790 Enzymes Proteins 0.000 claims description 39
- 102000004190 Enzymes Human genes 0.000 claims description 39
- 108010047357 Luminescent Proteins Proteins 0.000 claims description 38
- 102000006830 Luminescent Proteins Human genes 0.000 claims description 36
- 238000004020 luminiscence type Methods 0.000 claims description 31
- 238000001514 detection method Methods 0.000 claims description 30
- 230000003834 intracellular effect Effects 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 26
- 230000004044 response Effects 0.000 claims description 26
- 239000000758 substrate Substances 0.000 claims description 25
- 210000004900 c-terminal fragment Anatomy 0.000 claims description 22
- 210000004898 n-terminal fragment Anatomy 0.000 claims description 22
- 239000013598 vector Substances 0.000 claims description 20
- 102000005701 Calcium-Binding Proteins Human genes 0.000 claims description 18
- 108010045403 Calcium-Binding Proteins Proteins 0.000 claims description 18
- 102100032646 Opsin-5 Human genes 0.000 claims description 18
- 101710131039 Opsin-5 Proteins 0.000 claims description 17
- 108020004707 nucleic acids Proteins 0.000 claims description 17
- 102000039446 nucleic acids Human genes 0.000 claims description 17
- 150000007523 nucleic acids Chemical class 0.000 claims description 17
- 230000003993 interaction Effects 0.000 claims description 14
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 10
- 230000002207 retinal effect Effects 0.000 claims description 9
- 101001086282 Homo sapiens Opsin-5 Proteins 0.000 claims description 8
- 230000003197 catalytic effect Effects 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000006555 catalytic reaction Methods 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 230000002441 reversible effect Effects 0.000 claims 1
- 238000003384 imaging method Methods 0.000 description 27
- 238000010191 image analysis Methods 0.000 description 19
- 238000005259 measurement Methods 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 15
- 238000010586 diagram Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 239000012634 fragment Substances 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 10
- 102000000584 Calmodulin Human genes 0.000 description 10
- 108010041952 Calmodulin Proteins 0.000 description 10
- 229910001424 calcium ion Inorganic materials 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 241000122205 Chamaeleonidae Species 0.000 description 8
- 210000004102 animal cell Anatomy 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000004891 communication Methods 0.000 description 8
- 239000013604 expression vector Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 108060001084 Luciferase Proteins 0.000 description 6
- 210000004899 c-terminal region Anatomy 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 108090000331 Firefly luciferases Proteins 0.000 description 5
- 108010052090 Renilla Luciferases Proteins 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000003086 colorant Substances 0.000 description 5
- 239000013613 expression plasmid Substances 0.000 description 5
- 238000000520 microinjection Methods 0.000 description 5
- 239000005089 Luciferase Substances 0.000 description 4
- 108050001704 Opsin Proteins 0.000 description 4
- 102000010175 Opsin Human genes 0.000 description 4
- 102000007079 Peptide Fragments Human genes 0.000 description 4
- 108010033276 Peptide Fragments Proteins 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical group O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 3
- NCYCYZXNIZJOKI-HPNHMNAASA-N 11Z-retinal Natural products CC(=C/C=O)C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-HPNHMNAASA-N 0.000 description 3
- 108091006027 G proteins Proteins 0.000 description 3
- 102000030782 GTP binding Human genes 0.000 description 3
- 108091000058 GTP-Binding Proteins 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 230000001678 irradiating effect Effects 0.000 description 3
- 210000000287 oocyte Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 101150072531 10 gene Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 2
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 2
- 241000254158 Lampyridae Species 0.000 description 2
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 241000242739 Renilla Species 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108091006047 fluorescent proteins Proteins 0.000 description 2
- 102000034287 fluorescent proteins Human genes 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N C1CCCCC1 Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 102000034573 Channels Human genes 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001420836 Ophthalmitis Species 0.000 description 1
- 238000009193 PUVA therapy Methods 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 238000000225 bioluminescence resonance energy transfer Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 239000003269 fluorescent indicator Substances 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 208000010403 panophthalmitis Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000027425 release of sequestered calcium ion into cytosol Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- XOFLBQFBSOEHOG-UUOKFMHZSA-N γS-GTP Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=S)[C@@H](O)[C@H]1O XOFLBQFBSOEHOG-UUOKFMHZSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
[手順]
ヒト由来のオプシン5遺伝子の全長を合成し、動物細胞発現用プラスミドであるpcDNA3.1(インビトロジェン社製)のBamHI部位とEcoRI部位の間に挿入し、動物細胞発現用プラスミドpcDNA/OPN5を作製した。
[使用した鋳型]
pGL4.10(プロメガ(株)製)
[cpNLuc遺伝子作製用合成オリゴDNA配列]
cpNLuc_Fw(配列番号3):5’−ATCAGATCTGAAGATGCCAAAAACATTAAG−3’
cpNLuc_Rv(配列番号4):5’−CTAGAATTCTTAGTCCTTGTCGATGAGAGC−3’
[cpCLuc遺伝子作製用合成オリゴDNA配列]
cpCLuc_Fw(配列番号5):5’−TGTGGATCCAGCCACCATGAGCGGCTACGTTAACAACCCC−3’
cpCLuc_Rv(配列番号6):5’−CAGCTCGAGCACGGCGATCTTGCCGCCCTT−3’
[使用した鋳型]
カメレオン遺伝子(YC2.1)のcDNA
[CaM−M13遺伝子作製用合成オリゴDNA配列]
CaM−M13_Fw(配列番号7):5’−GCCCTCGAGCATGACCAACTGACAGAAGAG−3’
CaM−M13_Rv(配列番号8):5’−CATGGATCCCAGTGCCCCGGAGCTGGAGAT−3’
次に、HEK293細胞での紫外光照射によるカルシウム濃度変動の発光イメージングについて以下に説明を行う。
HEK293細胞をATCC社より入手し、5% CO2インキュベーター内で、10% Fetal Bovine Serum、および、1x Nonessential amino acidsを添加したEarle’s MEM/培地(GIBCO社製)で培養した。
細胞を直径35mmガラスボトムディッシュに、2x105/dishの細胞密度で播種し、5% CO2インキュベーター内で一晩培養し、紫外光感受性タンパク質発現用プラスミドpcDNA/OPN5、およびカルシウム感受性発光タンパク質発現用プラスミドpcDNA/cpGL4_C_CaM−M13_Nを、FuGENE HD(ロシュ社製)を用いてトランスフェクションを行い、5% CO2インキュベーター内で一晩培養した。
培地中にルシフェリン2mM(プロメガ社製)および11−cis−レチナール10μMを加え、1時間静置した。その後、発光顕微鏡LV(LUMINOVIEW)−200(オリンパス社製)にセットし、5秒間隔で発光画像のタイムラプス撮影を行った。発光観察条件として、対物レンズの倍率は40倍、露出時間は5〜10秒間、ビニングは1x1、EM−CCDカメラiXon(アンドール社製)を用い、画像解析装置110として構成したパーソナルコンピュータに取り込んだ。
タイムラプス撮影開始から5分後にCCDカメラのシャッターを閉じてから、ハロゲンランプ光源から330−380nmのバンドパスフィルターを通して紫外光照射(0.15〜1.0μW、10〜15秒間)を行い、照射後に再びCCDカメラのシャッターを開いて引き続き発光画像のタイムラプス撮影を行った。
手順3で撮影した各々の発光画像に対して複数のROI(Region of Interest:関心領域)を指定し(図9参照)、また、手順4で撮影した各々の発光画像に対して複数のROIを指定した(図10参照)。そして、指定した各ROIの発光強度を各々の発光画像に基づいて測定し、その発光強度の経時変化をグラフで表示した(図11参照)。発光画像の解析は、画像解析部110として機能するMetamorphソフトウェア(ユニバーサルイメージング社製)を用いて行った。
以上の実験の結果、ヒトのオプシン5タンパク質およびカルシウム感受性発光タンパク質cpGL4_C_CaM−M13_Nを利用することによって、紫外光刺激に対するカルシウム応答を発光強度の減少としてシングルセル(単一細胞)レベルで検出することができた(図9〜図11を参照)。
Claims (10)
- 紫外光に応答して細胞内カルシウム濃度を変化させる紫外光感受性タンパク質と細胞内カルシウム濃度に応答して発光反応に対する触媒作用が変化するカルシウム感受性発光タンパク質とを発現する細胞を作製する細胞作製工程と、
前記細胞に対し発光基質を添加する基質添加工程と、
前記細胞を紫外光にさらす暴露工程と、
前記カルシウム感受性発光タンパク質が触媒する発光反応が生じている細胞の発光画像を取得することにより該発光反応を検出する検出工程と、
前記検出の結果に基づいて、前記細胞に対する前記紫外光の照射量を細胞ごとに決定する照射量決定工程と
を含み、
前記紫外光感受性タンパク質は哺乳類オプシン5であり、前記カルシウム感受性発光タンパク質は、発光酵素のN末端側断片と、前記発光酵素のC末端側断片と、カルシウム結合領域と、前記カルシウム結合領域と可逆的に結合または解離できる相互作用領域とを含むカルシウムセンサータンパク質であって、前記カルシウム結合領域および前記相互作用領域は前記C末端側断片と前記N末端側断片との間に位置するカルシウムセンサータンパク質である、
紫外光測定方法。 - さらに、前記細胞に対しレチナールを添加するレチナール添加工程を含む請求項1に記載の方法。
- 前記検出工程は少なくとも前記暴露工程の前および後に行われる請求項1に記載の方法。
- 前記検出工程は経時的に繰り返して行われる請求項1に記載の方法。
- 前記検出工程は複数の異なる前記細胞に対して同時に行われる請求項1に記載の方法。
- 紫外光に応答して細胞内カルシウム濃度を変化させる紫外光感受性タンパク質と細胞内カルシウム濃度に応答して発光反応に対する触媒作用が変化するカルシウム感受性発光タンパク質とを発現する、請求項1〜請求項5のいずれか1項記載の方法のための細胞。
- 前記哺乳類オプシン5はヒトオプシン5である請求項6に記載の細胞。
- 前記カルシウムセンサータンパク質は配列番号1または2に記載のアミノ酸配列を含む請求項6に記載の細胞。
- 紫外光に応答して細胞内カルシウム濃度を変化させる紫外光感受性タンパク質の遺伝子の塩基配列を有する核酸と、細胞内カルシウム濃度に応答して発光反応に対する触媒作用が変化するカルシウム感受性発光タンパク質の遺伝子の塩基配列の核酸とを含む、請求項1〜請求項5のいずれか1項記載の方法のためのベクター。
- 紫外光に応答して細胞内カルシウム濃度を変化させる紫外光感受性タンパク質の遺伝子の塩基配列を有する核酸を含むベクターと、細胞内カルシウム濃度に応答して発光反応に対する触媒作用が変化するカルシウム感受性発光タンパク質の遺伝子の塩基配列の核酸を含むベクターとを含む、請求項1〜請求項5のいずれか1項記載の方法のためのベクターセット。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011063144A JP5875773B2 (ja) | 2011-03-22 | 2011-03-22 | 紫外光測定方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011063144A JP5875773B2 (ja) | 2011-03-22 | 2011-03-22 | 紫外光測定方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012196183A JP2012196183A (ja) | 2012-10-18 |
| JP5875773B2 true JP5875773B2 (ja) | 2016-03-02 |
Family
ID=47179094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011063144A Expired - Fee Related JP5875773B2 (ja) | 2011-03-22 | 2011-03-22 | 紫外光測定方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5875773B2 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014176363A (ja) * | 2013-03-15 | 2014-09-25 | Olympus Corp | 光受容体の光応答解析方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009153399A (ja) * | 2007-12-25 | 2009-07-16 | National Institute Of Advanced Industrial & Technology | 一分子型リアルタイム生物発光イメージングプローブ |
| JP5553326B2 (ja) * | 2008-04-25 | 2014-07-16 | 独立行政法人産業技術総合研究所 | 一分子型プローブ及びその利用 |
| US20100247446A1 (en) * | 2009-03-24 | 2010-09-30 | Olympus Corporation | Method and system for analyzing optical signal |
-
2011
- 2011-03-22 JP JP2011063144A patent/JP5875773B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012196183A (ja) | 2012-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Sustained deep-tissue voltage recording using a fast indicator evolved for two-photon microscopy | |
| Girven et al. | Probing deep brain circuitry: new advances in in vivo calcium measurement strategies | |
| US9664697B2 (en) | Green-to-red photo-convertible fluorescent calcium indicator | |
| Inagaki et al. | Genetically encoded bioluminescent voltage indicator for multi-purpose use in wide range of bioimaging | |
| JP5953293B2 (ja) | 発光タンパクによる長期モニタリング方法および解析方法 | |
| CN109553687B (zh) | 基于g蛋白偶联受体构建的荧光探针 | |
| CN101151378A (zh) | 规定部位发光量测定方法、规定部位发光量测定装置、表达量测定方法及测定装置 | |
| Zherdeva et al. | Long-term fluorescence lifetime imaging of a genetically encoded sensor for caspase-3 activity in mouse tumor xenografts | |
| JPWO2009075306A1 (ja) | 発光測定方法および発光測定システム | |
| Adam et al. | All-optical electrophysiology reveals brain-state dependent changes in hippocampal subthreshold dynamics and excitability | |
| Kuchmiy et al. | Methods for in vivo molecular imaging | |
| Afshar Saber et al. | All-optical assay to study biological neural networks | |
| Storace et al. | Genetically encoded protein sensors of membrane potential | |
| Ai et al. | Green-to-red photoconversion of GCaMP | |
| CN105461787A (zh) | 大斯托克斯位移荧光蛋白CyOFP及其应用 | |
| Liu et al. | A bright monomeric near-infrared fluorescent protein with an excitation peak at 633 nm for labeling cellular protein and reporting protein–protein interaction | |
| JP5800462B2 (ja) | 光シグナル解析方法 | |
| Fink et al. | PinkyCaMP a mScarlet-based calcium sensor with exceptional brightness, photostability, and multiplexing capabilities | |
| Abbondanza et al. | Dissection of neurochemical pathways across complexity and scale | |
| JP5875773B2 (ja) | 紫外光測定方法 | |
| JP2019216730A (ja) | バイオセンサーを有するヒト細胞モデル | |
| EP2436690A1 (en) | Reversibly photoswitchable polypeptides | |
| US20210155958A1 (en) | Bioluminescent markers of neural activity | |
| JP2014176363A (ja) | 光受容体の光応答解析方法 | |
| JP5893241B2 (ja) | カルシウム解析方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140319 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150602 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150803 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160105 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160120 |
|
| R151 | Written notification of patent or utility model registration |
Ref document number: 5875773 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |